Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Human CD32b/c Protein, Strep Tag (Cat. No. CDB-H5284) immobilized on CM5 Chip can bind Rituximab with an affinity constant of 10.2 μM as determined in a SPR assay (Biacore 8K) (QC tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Obexelimab | XmAb-5871; AMG-729 | Phase 3 Clinical | Xencor Inc | Immunoglobulin G4-Related Disease; Multiple Sclerosis; Lupus Erythematosus, Systemic; Anemia, Hemolytic, Autoimmune | Details |
| PRV-3279 | HDM-3002; MGD-010; PRV-3279; CD32BxCD79B | Phase 2 Clinical | Macrogenics Inc | Lupus Erythematosus, Systemic | Details |
| BI-1206 | 6G-11; BI-1206 | Phase 2 Clinical | Bioinvent International Ab | Lymphoma, B-Cell; Solid tumours; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
| BI-1607 | BI-1607 | Phase 2 Clinical | Bioinvent International Ab | Solid tumours; Skin Melanoma; Esophageal Neoplasms; Stomach Neoplasms; Uveal melanoma; Breast Neoplasms; Metastatic breast cancer; Melanoma; Adenocarcinoma | Details |
| NVG-2089 | NVG-2089 | Phase 1 Clinical | Nuvig Therapeutics Inc | Details |
This web search service is supported by Google Inc.
A-Z
